Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-05-17 @ 4:02 PM
Study NCT ID:
NCT00688493
Status:
COMPLETED
Last Update Posted:
2012-03-21
First Post:
2008-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effects of Single Oral Dose Dapagliflozin QT Study
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D1690C00001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |